In recent years, there has been considerable interest in using microalgal lipids in the food, chemical, pharmaceutical, and cosmetic industries. Several microalgal species can accumulate appreciable lipid quantities and therefore are characterized as oleaginous. In cosmetic formulations, lipids and their derivatives are one of the main ingredients. Different lipid classes are great moisturizing, emollient, and softening agents, work as surfactants and emulsifiers, give consistence to products, are color and fragrance carriers, act as preservatives to maintain products integrity, and can be part of the molecules delivery system. In the past, chemicals have been widely used but today’s market and customers’ demands are oriented towards natural products. Microalgae are an extraordinary source of lipids and other many bioactive molecules. Scientists’ attention to microalgae cultivation for their industrial application is increasing. For the high costs associated, commercialization of microalgae and their products is still not very widespread. The possibility to use biomass for various industrial purposes could make microalgae more economically competitive.

The need to safeguard our planet by reducing carbon dioxide emissions has led to a significant development of research in the field of alternative energy sources. Hydrogen has proved to be the most promising molecule, as a fuel, due to its low environmental impact. Even if various methods already exist for producing hydrogen, most of them are not sustainable. Thus, research focuses on the biological sector, studying microalgae, and other microorganisms’ ability to produce this precious molecule in a natural way. In this review, we provide a description of the biochemical and molecular processes for the production of biohydrogen and give a general overview of one of the most interesting technologies in which hydrogen finds application for electricity production: fuel cells.

Feeding a growing global population requires sustainable, innovative, and cost-effective solutions, especially in light of the environmental damage and nutrient imbalances caused by excessive chemical fertilizer use. Microalgae have gained prominence due to their phylogenetic diversity, physiological adaptability, eco-compatible characteristics, and potential to support regenerative agriculture and mitigate climate change. Functioning as biofertilizers, biostimulants, and bioremediators, microalgae accelerate nutrient cycling, improve soil aggregation through extracellular polymeric substances (EPSs), and stimulate rhizospheric microbial diversity. Empirical studies demonstrate their ability to increase crop yields by 5–25%, reduce chemical nitrogen inputs by up to 50%, and boost both organic carbon content and enzymatic activity in soils. Their application in saline and degraded lands further promotes resilience and ecological regeneration. Microalgal cultivation platforms offer scalable in situ carbon sequestration, converting atmospheric carbon dioxide (CO₂) into biomass with potential downstream vaporization into biofuels, bioplastics, and biochar, aligning with circular economy principles. While the commercial viability of microalgae is challenged by high production costs, technical complexities, and regulatory gaps, recent breakthroughs in cultivation systems, biorefinery integration, and strain optimization highlight promising pathways forward. This review highlights the strategic importance of microalgae in enhancing climate resilience, promoting agricultural sustainability, restoring soil health, and driving global bioeconomic transformation.

Crude oil is one of the major pollutants present. Its extraction and processing generate processing waters contaminated by hydrocarbons which are harmful to both human health and the flora and fauna that come into contact with it. Hydrocarbon contamination can involve soil and water, and several technologies are used for recovery. The most used techniques for the recovery of spilt oil involve chemical-physical methods that can remove most of the pollutants. Among these, must consider the bioremediation by microorganisms, mostly bacterial capable of degrading many of the toxic compounds contained within the petroleum. Microalgae participate in bioremediation indirectly, supporting the growth of degrading bacteria, and directly acting on contaminants. Their direct contribution is based on the activation of various mechanisms ranging from the production of enzymes capable of degrading hydrocarbons, such as lipoxygenases, to the attack through the liberation of free radicals. The following review analyzed all the works published in the last ten years concerning the ability of microalgae to remove hydrocarbons, intending to identify in these microorganisms an alternative technology to the use of bacteria. The advantages of using microalgae concern not only their ability to remove toxic compounds and release oxygen into the atmosphere but their biomass could then be used in a circular economy process to produce biofuels.

Tumor Necrosis Factor-alpha (TNFα) rs1800629 (-308G>A) is a single nucleotide polymorphism (SNP) related to variable responses to anti-TNFα therapy. This therapy is efficient in severe and refractory manifestation of Behçet syndrome (BS), an auto-inflammatory systemic vasculitis. We investigated (1) the association between rs1800629 genotypes and responses to therapy and (2) the correlation between SNP and clinical patterns in a cohort of 74 BS Italian patients receiving anti-TNFα therapy with a follow-up of at least 12 months. The rs1800629 was genotyped through amplification, direct sequencing and bioinformatics analyses. The rs1800629 GG and GA genotypes were assessed as predictors of outcomes dividing the patients between therapy responders and non-responders. The rs1800629 GG and GA genotypes were found, respectively, in 59/74 (79.7%) and 15/74 BS patients (21.3%) (p < 0.05). We identified 16/74 (21.9%) non-responder patients, of which 9/16 (56.3%) showed the GG genotype and 7/16 (43.7%) the GA genotype. A total of 50/58 (86.2%) responder patients showed the GG genotype, and 8/58 (13.8%) the GA genotype (p < 0.05). The percentage of non-responder females (68.8%) was significantly higher than non-responder males (31.2%) (p < 0.05). No correlation between SNP and clinical patterns was observed. To successfully include rs1800629 as a predictive biomarker of TNFα inhibitor response, genome-wide association studies in larger, well-characterised cohorts are required.